Structure Therapeutics Inc.
GPCR
$15.05
-$0.22-1.44%
| Weiss Ratings | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.71 | |||
| Price History | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.69% | |||
| 30-Day Total Return | -34.05% | |||
| 60-Day Total Return | -40.70% | |||
| 90-Day Total Return | -55.41% | |||
| Year to Date Total Return | -46.61% | |||
| 1-Year Total Return | -62.66% | |||
| 2-Year Total Return | -39.14% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -75.66% | |||
| 52-Week Low % Change | 15.51% | |||
| Price | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $62.74 | |||
| 52-Week Low Price | $13.22 | |||
| 52-Week Low Price (Date) | Apr 09, 2025 | |||
| 52-Week High Price (Date) | Jun 03, 2024 | |||
| Valuation | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 875.63M | |||
| Enterprise Value | -4.03M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -6.95 | |||
| Earnings Per Share Growth | -7.82% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.34 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $15.05 | |||
| Enterprise Value/EBITDA (TTM) | 0.03 | |||
| Enterprise Value/EBIT | 0.03 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 19.10M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 457 1978 | |||
| Address | 601 Gateway Boulevard South San Francisco, CA 94080 | |||
| Website | structuretx.com | |||
| Country | United States | |||
| Year Founded | 2016 | |||
| Profitability | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -14.28% | |||
| Return on Equity | -- | |||
| Income Statement | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -157.23M | |||
| EBIT (TTM) | -158.23M | |||
| Net Income (TTM) | -122.53M | |||
| Net Income Avl. to Common (TTM) | -122.53M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -48.88% | |||
| EPS Diluted (TTM) | -6.95 | |||
| EPS Diluted Growth (Q YOY) | -20.38% | |||
| Balance Sheet | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 883.52M | |||
| Cash Per Share (Q) | $46.26 | |||
| Total Current Assets (Q) | 891.21M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 864.84M | |||
| Current Ratio (Q) | 24.741 | |||
| Book Value Per Share (Q) | $45.29 | |||
| Total Assets (Q) | 903.33M | |||
| Total Current Liabilities (Q) | 36.02M | |||
| Total Debt (Q) | 3.86M | |||
| Total Liabilities (Q) | 38.49M | |||
| Total Common Equity (Q) | 864.84M | |||
| Cash Flow | GPCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -358.91M | |||
| Cash from Financing (TTM) | 515.26M | |||
| Net Change in Cash (TTM) | 39.72M | |||
| Levered Free Cash Flow (TTM) | -70.78M | |||
| Cash from Operations (TTM) | -116.64M | |||
